Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors
Daniel Shouval, Ruth Adler, Yaron Ilan – 1 June 1993 – Recipients of allogeneic bone marrow transplantation are immunosuppressed as a result of their primary disease and by myeloablative therapy. Such patients are dependent on multiple blood products and are at risk for hepatitis B virus infection. Active immunization against hepatitis B in the immediate pre‐ and post‐transplant periods is ineffective, pre‐ sumably because of decreased T cell–dependent B‐cell responses.